Recombinant live vaccine

Recombinant Live Vaccine

Edward Jenner, pioneer of vaccination

A recombinant live vaccine is a type of vaccine that uses a live organism that has been genetically engineered to express antigens from a pathogen. These vaccines aim to elicit a strong and long-lasting immune response by mimicking a natural infection without causing disease.

Mechanism of Action

Recombinant live vaccines work by introducing a live, attenuated organism into the body. This organism has been genetically modified to express antigens from a pathogen of interest. When administered, the vaccine organism replicates in the host, presenting the antigens to the immune system. This process stimulates both the humoral immune response and the cell-mediated immune response, leading to the production of antibodies and the activation of T cells.

Activation of T and B cells

The immune system recognizes the antigens as foreign, mounts a response, and "remembers" the pathogen. This memory allows for a rapid and effective response upon subsequent exposure to the actual pathogen.

Advantages

Recombinant live vaccines offer several advantages:

• Strong Immune Response: They elicit a robust immune response due to their ability to replicate and present antigens in a manner similar to natural infection.
• Long-lasting Immunity: Often, a single dose can provide long-lasting immunity, reducing the need for booster shots.
• Broad Protection: They can induce both humoral and cell-mediated immunity, providing comprehensive protection.

Challenges and Considerations

Despite their advantages, recombinant live vaccines also present challenges:

• Safety Concerns: There is a risk, albeit low, that the live organism could revert to a virulent form or cause disease in immunocompromised individuals.
• Stability: Live vaccines require careful handling and storage to maintain their efficacy.
• Regulatory Hurdles: The development and approval process for recombinant live vaccines can be complex and time-consuming.

Examples

Several recombinant live vaccines have been developed and are in use or under investigation:

• Recombinant BCG Vaccine: Modified versions of the Bacillus Calmette-Guérin (BCG) vaccine are being explored for enhanced protection against tuberculosis.
• Recombinant Viral Vector Vaccines: These include vaccines that use viruses like adenovirus or vesicular stomatitis virus (VSV) to deliver antigens from pathogens such as Ebola or COVID-19.

Future Directions

The field of recombinant live vaccines is rapidly evolving, with ongoing research focused on improving safety, efficacy, and delivery methods. Advances in genetic engineering and synthetic biology hold promise for the development of novel vaccines against a wide range of infectious diseases.

Pneumococcal conjugate vaccine

Related Pages

• Vaccine
• Immunology
• Genetic engineering
• Viral vector vaccine

   This article is a  stub. You can help WikiMD by expanding it!